From its UK offices, Lambda provides a full range of Pharmacovigilance (PV) services that offer a cost-effective solution to maintain the PV function without the cost of in-house staff and resources. This team is backed by QUALITY Assurance approach and flexibility, assures efficacy while delivering services.
Lambda Therapeutic Research uses 21 CFR Part 11 solutions for collecting, storing, maintaining, retrieving and managing Adverse Event (AE) Data and for generating various regulatory reports. Lambda Canada also manages Medical Inquiries for North America (USA, Canada, and PuertoRico).
The central lab at Lambda Therapeutic Research has vast experience working for various clinical trials involving specialties like COPD, CVS, Oncology, Diabetes, CNS, Orthopedic, etc. and PK studies of macromolecule e.g. LMWH.
Lambda Therapeutic Research has the expertise to offer you the entire range of services for First-in-man and Phase I clinical trials. Our capabilities lie in designing the protocol, conducting the study, generation of the clinical study report and the regulatory submission.
Lambda India has experience with Phase II to IV studies, ranging from single center studies with 20 patients to large trials with over 5,000 patients. Operations are regionally based in India and locally managed across Central & Eastern Europe.